ST上昇性心筋梗塞の患者の迅速な初期トリアージのための単純なリスク指数:InTIME IIサブスタディ
D A Morrow1, E M Antman, R P Giugliano
1TIMI Trials Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. damorrow@bics.bwh.harvard.edu
Lancet (London, England)
|November 22, 2001
まとめ
年齢,心拍数,シストリック血圧を用いた単純なリスクインデックスは,ST上昇心筋梗塞 (STEMI) 患者の死亡率を正確に予測します. このツールは,よりよい緊急心臓ケアのための迅速なトリアジを助けます.
科学分野:
- 心臓病学 心臓病学
- 緊急医療 緊急医療
- 臨床リスクの予測
背景:
- 効果的なトリアージは,ST上昇心筋梗塞 (STEMI) 患者のアウトカムにとって極めて重要です.
- 既存のSTEMIの死亡率予測モデルは複雑で,多くの場合多数の変数を使用しています.
- 年齢,心拍数,血圧は,STEMI死亡率の一貫した強力な予測要因です.
研究 の 目的:
- STEMI患者の30日間の死亡率を予測するための単純なリスクインデックスを開発し,検証する.
- 迅速な臨床トリアージにおけるインデックスの有用性を評価する.
- 単純なインデックスで重要な予後情報を把握できるかどうかを判断する.
主な方法:
- InTIME II試験 (n=13,253) の年齢,心拍数,静脈血圧 (SBP) を用いたリスク指数を開発しました.
- 式: (心拍数x [年齢/10]) /SBP.
- TIMI 9試験 (n=3659) から独立したコホートでインデックスを検証しました.
主要な成果:
- リスク指数は,強く独立して死亡率を予測した (c-statistic=0.78).
- クインティルに分類すると,20倍以上の死亡率のグラデーション (0.8%から17.4%) が示された.
- インデックスは,非常に早期のイベント (24時間以内に死亡,c-statistic=0.81) を正確に予測し,強力な外部検証を示しました.
結論:
- 簡単に評価できる変数を用いた単純なリスクインデックスは,STEMIの死亡率を効果的に予測します.
- このツールは,複雑なモデルと比較してリスクの階層化を簡素化します.
- このインデックスは,病院前および病院内でのSTEMI患者の迅速なトリアージに役立ちます.
さらに関連する動画
関連する概念動画
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...


